Taub v. Arrayit Corporation

CourtDistrict Court, S.D. New York
DecidedMarch 30, 2023
Docket1:15-cv-01366
StatusUnknown

This text of Taub v. Arrayit Corporation (Taub v. Arrayit Corporation) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Taub v. Arrayit Corporation, (S.D.N.Y. 2023).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK --------------------------------------------------------------------- x REUBEN TAUB, IRWIN L. ZALCBERG and THE : IRWIN ZALCBERG PROFIT SHARING PLAN, : : Plaintiffs, : 15-CV-1366 (ALC)(JLC) : -against- : ORDER ON MOTION IN : LIMINE ARRAYIT CORPORATION, RENE SCHENA, : MARK SCHENA, and TODD MARTINSKY, : : Defendants. : : : --------------------------------------------------------------------- : x ANDREW L. CARTER, JR., District Judge: Plaintiffs Reuben Taub, Irwin L. Zalcberg and the Irwin Zalcberg Profit Sharing Plan (the “Plan,” and collectively, the “Plaintiffs”) brought this action against Defendants Arrayit Corporation, Rene Schena, Mark Schena, and Todd Martinsky (collectively, the “Defendants”), alleging breach of contract and fraudulent inducement of their investments. After extensive motion practice and the close of discovery, the parties were ordered to file their pretrial submissions by March 23, 2022 in anticipation of a bench trial originally scheduled for April 5, 2022. See Minute Entry of Feb. 11, 2022. Plaintiffs submitted their pretrial filings in a timely manner. To date, Defendants have not filed any pretrial submissions, nor asked the Court for an extension of time to do so. Therefore, the Court will treat Plaintiffs’ submissions as unopposed. District courts have discretion to determine evidentiary issues presented in motions in limine in advance of trial. See, e.g., United States v. Dupree, 706 F.3d 131, 135 (2d Cir. 2013); Henry v. Wyeth Pharm., Inc., 616 F.3d 134, 149 (2d Cir. 2010). The purpose of a motion in limine “is to aid the trial process by enabling the Court to rule in advance of trial on the relevance of certain forecasted evidence, as to issues that are definitely set for trial, without lengthy argument at, or interruption of, the trial.” Palmieri v. Defaria, 88 F.3d 136, 141 (2d Cir. 1996). As Defendants have filed no opposition despite over a year of delay, Plaintiffs’ motion in limine at ECF No. 232-234 is granted in its entirety as unopposed. The Court previously issued an OSHOW as to why the plaintiffs’ motion in limine and trial submissions should not be treated as unopposed and why the Court should not enter judgment in favor of plaintiffs. ECF No. 265. The Court grants the motion in limine, but declines to enter judgment based on Defendant’s failure to oppose the motion in limine or submit pretrial materials. However, Plaintiffs are granted leave to file a motion to enforce the parties’ unsigned Settlement Agreement. See ECF No. 264. Plaintiffs Initial Brief: April 14, 2023 Defendant’s Opposition: April 28, 2023 Plaintiff's Reply (if any): May 5, 2023 The Clerk of Court is respectfully directed to terminate the open motions at ECF No. 232.

SO ORDERED.

Dated: New York, New York March 30, 2023 (Ant. 7 Cmg ANDREWL. CARTER, JR. United States District Judge

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Henry v. Wyeth Pharmaceuticals, Inc.
616 F.3d 134 (Second Circuit, 2010)
United States v. Dupree
706 F.3d 131 (Second Circuit, 2013)
Palmieri v. Defaria
88 F.3d 136 (Second Circuit, 1996)

Cite This Page — Counsel Stack

Bluebook (online)
Taub v. Arrayit Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/taub-v-arrayit-corporation-nysd-2023.